However, at doses above the saturation threshold (approximately 1 mcg/kg), GHRP-6 stimulates adrenocorticotropic hormone (ACTH) release, leading to elevated cortisol, and increases prolactin secretion from lactotroph cells
Our quality assurance process ensures consistent peptide integrity and purity across all shipments to Canadian research institutions
CJC-1295 without DAC (MOD GRF 1-29), which we more commonly use in combination protocols, has a half-life of roughly 30 minutes still longer than sermorelin, and when paired with Ipamorelin, the combined effect produces a more sustained and powerful GH elevation
Limitations and Evidence Gaps The ipamorelin research base has substantial gaps: No completed phase 3 trials
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
